Literature DB >> 19762501

The lymphatic tissue microenvironments in chronic lymphocytic leukemia: in vitro models and the significance of CD40-CD154 interactions.

Jan A Burger, Varsha Gandhi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19762501      PMCID： PMC4969051          DOI： 10.1182/blood-2009-06-228981

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

1.  Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1.

Authors:  J A Burger; N Tsukada; M Burger; N J Zvaifler; M Dell'Aquila; T J Kipps
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

2.  Differential regulation of gene expression following CD40 activation of leukemic compared to healthy B cells.

Authors:  Clair S Gricks; David Zahrieh; A Jason Zauls; Gullu Gorgun; Daniela Drandi; Katja Mauerer; Donna Neuberg; John G Gribben
Journal:  Blood       Date:  2004-05-25       Impact factor: 22.113

3.  Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.

Authors:  Paolo Ghia; Giuliana Strola; Luisa Granziero; Massimo Geuna; Giuseppe Guida; Federica Sallusto; Nancy Ruffing; Licia Montagna; Paola Piccoli; Marco Chilosi; Federico Caligaris-Cappio
Journal:  Eur J Immunol       Date:  2002-05       Impact factor: 5.532

4.  Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells.

Authors:  L Lagneaux; A Delforge; D Bron; C De Bruyn; P Stryckmans
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

5.  Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1.

Authors:  Irene M Pedersen; Shinichi Kitada; Lorenzo M Leoni; Juan M Zapata; James G Karras; Nobuhiro Tsukada; Thomas J Kipps; Yong Sung Choi; Frank Bennett; John C Reed
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

Review 6.  CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers.

Authors:  J A Burger; A Peled
Journal:  Leukemia       Date:  2008-11-06       Impact factor: 11.528

7.  Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a.

Authors:  Tetsuya Fukuda; Liguang Chen; Tomoyuki Endo; Li Tang; Desheng Lu; Januario E Castro; George F Widhopf; Laura Z Rassenti; Mark J Cantwell; Charles E Prussak; Dennis A Carson; Thomas J Kipps
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

8.  B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.

Authors:  Maite P Quiroga; Kumudha Balakrishnan; Antonina V Kurtova; Mariela Sivina; Michael J Keating; William G Wierda; Varsha Gandhi; Jan A Burger
Journal:  Blood       Date:  2009-06-02       Impact factor: 22.113

9.  Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia.

Authors:  Meike Vogler; Michael Butterworth; Aneela Majid; Renata J Walewska; Xiao-Ming Sun; Martin J S Dyer; Gerald M Cohen
Journal:  Blood       Date:  2008-11-13       Impact factor: 22.113

10.  Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.

Authors:  E A Ranheim; T J Kipps
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307
View more
  9 in total

Review 1.  Postulated mechanisms of resistance of B-cell non-Hodgkin lymphoma to rituximab treatment regimens: strategies to overcome resistance.

Authors:  Benjamin Bonavida
Journal:  Semin Oncol       Date:  2014-08-12       Impact factor: 4.929

2.  Novel Molecular Mechanism of Regulation of CD40 Ligand by the Transcription Factor GLI2.

Authors:  Weiguo Han; David A Jackson; Stephan J Matissek; Jason A Misurelli; Matthew S Neil; Brandon Sklavanitis; Nansalmaa Amarsaikhan; Sherine F Elsawa
Journal:  J Immunol       Date:  2017-05-01       Impact factor: 5.422

3.  Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations.

Authors:  John C Riches; Conor J O'Donovan; Sarah J Kingdon; Fabienne McClanahan; Andrew J Clear; Donna S Neuberg; Lillian Werner; Carlo M Croce; Alan G Ramsay; Laura Z Rassenti; Thomas J Kipps; John G Gribben
Journal:  Blood       Date:  2014-05-14       Impact factor: 22.113

4.  Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL.

Authors:  Marco Haselager; Rachel Thijssen; Christopher West; Louise Young; Roel Van Kampen; Elaine Willmore; Simon Mackay; Arnon Kater; Eric Eldering
Journal:  Cell Death Differ       Date:  2021-01-25       Impact factor: 15.828

5.  Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy.

Authors:  A H Nwabo Kamdje; G Bassi; L Pacelli; G Malpeli; E Amati; I Nichele; G Pizzolo; M Krampera
Journal:  Blood Cancer J       Date:  2012-05-25       Impact factor: 11.037

6.  BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo.

Authors:  Cédric Schleiss; Wassila Ilias; Ouria Tahar; Yonca Güler; Laurent Miguet; Caroline Mayeur-Rousse; Laurent Mauvieux; Luc-Matthieu Fornecker; Elise Toussaint; Raoul Herbrecht; Frédéric Bertrand; Myriam Maumy-Bertrand; Thierry Martin; Sylvie Fournel; Philippe Georgel; Seiamak Bahram; Laurent Vallat
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

Review 7.  Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.

Authors:  Carlos Cuesta-Mateos; Jennifer R Brown; Fernando Terrón; Cecilia Muñoz-Calleja
Journal:  Front Immunol       Date:  2021-03-24       Impact factor: 7.561

8.  Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia.

Authors:  Pedro G Ferreira; Pedro Jares; Daniel Rico; Gonzalo Gómez-López; Alejandra Martínez-Trillos; Neus Villamor; Simone Ecker; Abel González-Pérez; David G Knowles; Jean Monlong; Rory Johnson; Victor Quesada; Sarah Djebali; Panagiotis Papasaikas; Mónica López-Guerra; Dolors Colomer; Cristina Royo; Maite Cazorla; Magda Pinyol; Guillem Clot; Marta Aymerich; Maria Rozman; Marta Kulis; David Tamborero; Anaïs Gouin; Julie Blanc; Marta Gut; Ivo Gut; Xose S Puente; David G Pisano; José Ignacio Martin-Subero; Nuria López-Bigas; Armando López-Guillermo; Alfonso Valencia; Carlos López-Otín; Elías Campo; Roderic Guigó
Journal:  Genome Res       Date:  2013-11-21       Impact factor: 9.043

9.  Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines.

Authors:  Paolo Giannoni; Cecilia Marini; Giovanna Cutrona; Serena Matis; Maria Cristina Capra; Francesca Puglisi; Paola Luzzi; Simona Pigozzi; Gabriele Gaggero; Antonino Neri; Katia Todoerti; Fortunato Morabito; Adalberto Ibatici; Maurizio Miglino; Micaela Bergamaschi; Silvia Bruno; Gian Mario Sambuceti; Jean Louis Ravetti; Manlio Ferrarini; Franco Fais; Daniela de Totero
Journal:  Haematologica       Date:  2021-10-01       Impact factor: 9.941
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.